Patents by Inventor Atta Behfar

Atta Behfar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160220357
    Abstract: Devices provided herein can include implantable transseptal flow control components adapted to be implanted in an opening in a septal wall. In a closed configuration, the implantable transseptal flow control components provided herein prevent blood from flowing through the opening. In an open configuration, the implantable transseptal flow control components provided herein allow blood to flow from the left atrium to the right atrium. In a closed configuration, implantable transseptal flow control components provided herein can be configured such that blood does not stagnate at a location proximate to a left atrium flow control component side when the pressure differential is below a second predetermined threshold pressure value. Implantable transseptal flow control components provided herein can remain in a closed configuration when a pressure differential between the left atrium and the right atrium is less than a first non-zero predetermined threshold pressure value.
    Type: Application
    Filed: February 4, 2016
    Publication date: August 4, 2016
    Inventors: Umang Anand, Raghav Goel, Roger W. McGowan, Daniel Ross, Patrick A. Haverkost, Mary M. Byron, David R. Wulfman, James P. Rohl, Peter M. Pollak, Lyle J. Olson, Atta Behfar, Charles J. Bruce
  • Publication number: 20160206697
    Abstract: This document provides methods and materials for reducing the risk of major adverse cardiac events. For example, methods and materials for identifying patients at risk of experiencing a major adverse cardiac event as well as methods and material for treating patients at risk of experiencing a major adverse cardiac event (e.g., patients who underwent percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI)) are provided.
    Type: Application
    Filed: September 3, 2014
    Publication date: July 21, 2016
    Inventors: Atta BEHFAR, Andre TERZIC, Ruben Jose CRESPO-DIAZ
  • Publication number: 20150360009
    Abstract: Multifunctional occlusion crossover devices include features to improve the crossover balloon occlusion technique used during transcatheter aortic valve replacement procedures, for example. The devices include a compliant balloon incorporated with a highly flexible and lubricous sheath system. The balloon is capable of safely occluding from the common iliac artery and down to an access site in the femoral artery. The devices can simplify the CBOT technique and replace multiple devices currently used for the procedure.
    Type: Application
    Filed: June 12, 2015
    Publication date: December 17, 2015
    Inventors: Roger McGowan, Kim Davis, Rachel Japuntich, Umang Anand, Raghav Goel, Peter M. Pollak, Douglas Pennington, Atta Behfar, Charles J. Bruce, Paul A. Friedman, Bruce D. Johnson, Lyle D. Joyce, Lyle J. Olson
  • Patent number: 8962320
    Abstract: This document provides methods and materials for treating cardiovascular tissue. For example, stem cells, compositions containing stem cells, methods for obtaining stem cells, compositions for generating stem cells expressing particular markers, and methods for repairing cardiovascular tissue are provided.
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: February 24, 2015
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Andre Terzic, Atta Behfar
  • Publication number: 20140348803
    Abstract: This document relates to compositions containing cardiogenic factors, to methods to obtain cells by culturing initial cells in the presence of such factors; and methods of administering the obtained cells to heart tissue.
    Type: Application
    Filed: August 6, 2014
    Publication date: November 27, 2014
    Inventors: Andre Terzic, Atta Behfar
  • Patent number: 8835384
    Abstract: This document relates to compositions containing cardiogenic factors, to methods to obtain cells by culturing initial cells in the presence of such factors; and methods of administering the obtained cells to heart tissue.
    Type: Grant
    Filed: May 20, 2009
    Date of Patent: September 16, 2014
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Andre Terzic, Atta Behfar
  • Publication number: 20120178164
    Abstract: This document provides methods and materials for treating cardiovascular tissue. For example, stem cells, compositions containing stem cells, methods for obtaining stem cells, compositions for generating stem cells expressing particular markers, and methods for repairing cardiovascular tissue are provided.
    Type: Application
    Filed: March 28, 2012
    Publication date: July 12, 2012
    Inventors: Andre Terzic, Atta Behfar
  • Patent number: 8173118
    Abstract: This document provides methods and materials for treating cardiovascular tissue. For example, stem cells, compositions containing stem cells, methods for obtaining stem cells, compositions for generating stem cells expressing particular markers (e.g., compositions comprising TGF-?1, BMP-2, FGF-4, and leukemia inhibitory factor), and methods for repairing cardiovascular tissue are provided.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: May 8, 2012
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Andre Terzic, Atta Behfar
  • Publication number: 20120100533
    Abstract: This document is related to a method for determining the cardio-generative potential of mammalian cells which comprises the assessment of a CARdiac generation Potential Index (CARPI) as a function of the quantification of the expression of genes of said cells. It also relates to a method for quantitatively assessing the modification of this cardio-generative potential and the cardiogenic potential of a treatment aiming at cellular differentiation.
    Type: Application
    Filed: May 20, 2010
    Publication date: April 26, 2012
    Applicants: CARDIO3 BIOSCIENCES SA, MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Andre Terzic, Atta Behfar, Roland Gordon-Beresford, Vinciane Gaussin, Christian Homsy
  • Publication number: 20110117065
    Abstract: This document relates to compositions containing cardiogenic factors, to methods to obtain cells by culturing initial cells in the presence of such factors; and methods of administering the obtained cells to heart tissue.
    Type: Application
    Filed: May 20, 2009
    Publication date: May 19, 2011
    Inventors: Andre Terzic, Atta Behfar
  • Publication number: 20100189697
    Abstract: This document provides methods and materials related to treating cardiovascular tissue (e.g., heart tissue or vascular tissue). For example, stem cells (e.g., CXCR4+/Flk-1+ stem cells), compositions containing stem cells, methods for obtaining stem cells, and methods for repairing cardiovascular tissue are provided.
    Type: Application
    Filed: March 7, 2008
    Publication date: July 29, 2010
    Inventors: Andre Terzic, Atta Behfar, Timothy J. Nelson
  • Publication number: 20080213214
    Abstract: This document provides methods and materials for treating cardiovascular tissue. For example, stem cells, compositions containing stem cells, methods for obtaining stem cells, compositions for generating stem cells expressing particular markers, and methods for repairing cardiovascular tissue are provided.
    Type: Application
    Filed: July 29, 2005
    Publication date: September 4, 2008
    Applicant: Mayo Foundation For Medical Education And Research
    Inventors: Andre Terzic, Atta Behfar
  • Publication number: 20080019944
    Abstract: This document provides methods and materials relating to cardiac cells. For example, this document provides methods and materials that can be used to obtain cells having the ability to differentiate into cardiomyocytes. Such cells can be used to repair damaged heart tissue. For example, cells having the ability to differentiate into cardiomyocytes can be used to repair or regenerate heart tissue in patients with a cardiac condition (e.g., ischemic cardiomyopathy, myocardial infarction, or heart failure).
    Type: Application
    Filed: February 13, 2007
    Publication date: January 24, 2008
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Andre Terzic, Atta Behfar